SLXN
Silexion Therapeutics Corp
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Under these circumstances, in accordance with the requirements of Accounting Standards Codification (“ASC”) 205-40, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern, as management believes its current funds will be sufficient to fund its operations for only several months from the date these financial statements are issued.”View the 10-Q filed May 15, 2026
Company with tickers: SLXN, SLXNW
Market Cap
$9.29M
Shares Outstanding
3,330,785
CIK
2022416
CUSIP
G1281K130
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Investor Relations
Investor relations
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.